The aim of this two-day symposium is to provide the Assisted Reproduction Technologies (ART) community an overview of fast-approaching technologies that may allow us to improve our assessment of the reproductive potential of gametes and embryos. These emerging technologies will allow clinicians and scientists in the IVF laboratory to assess gametes and embryos at the four basic levels of cell biology: DNA, RNA, proteins and metabolites. A variety of technologies, that will soon be available or are currently available to laboratories today, based on the “omics” - genomics, transcriptomics, proteomics and metabolomics - will be discussed by internationally recognized experts. The symposium will culminate in the faculty engaging participants in a debate regarding the merits of invasive vs. non-invasive embryo assessment.
This program is designed to facilitate full engagement by young investigators and offers ample opportunities for discussion and networking.
